LifeStance Health SG&A Expenses 2020-2026 | LFST
LifeStance Health sg&a expenses from 2020 to 2026. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
|
LifeStance Health Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025 | $382 |
| 2024 | $363 |
| 2023 | $411 |
| 2022 | $378 |
| 2021 | $434 |
| 2020 | $73 |
| 2019 | $41 |
|
LifeStance Health Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | $100 |
| 2025-12-31 | $95 |
| 2025-09-30 | $96 |
| 2025-06-30 | $97 |
| 2025-03-31 | $94 |
| 2024-12-31 | $94 |
| 2024-09-30 | $85 |
| 2024-06-30 | $95 |
| 2024-03-31 | $89 |
| 2023-12-31 | $93 |
| 2023-09-30 | $131 |
| 2023-06-30 | $102 |
| 2023-03-31 | $85 |
| 2022-12-31 | $90 |
| 2022-09-30 | $81 |
| 2022-06-30 | $104 |
| 2022-03-31 | $103 |
| 2021-12-31 | $153 |
| 2021-09-30 | $163 |
| 2021-06-30 | $85 |
| 2021-03-31 | $33 |
| 2020-12-31 | $24 |
| 2020-09-30 | $20 |
| 2020-06-30 | $16 |
| 2020-03-31 | $14 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.495B | $1.424B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |